STAAR Surgical Inc’s (NASDAQ: STAA) received an average “buy” rating from ten stock market analysts. Out of the ten, four issued a rating of “hold” and five issued a rating of “Buy”. The one-year target price average among stock market brokers is $62.40.
Which Stock Market Analysts Issue What Rating To NASDAQ: STAA?
Stephens upgraded its price target for NASDAQ: STAA to $63.00 from $44.00. They also gave STAAR Surgical a rating of “overweight” on 8th July during the Wednesday report. Sidoti increased its rating to a “buy” from a rating of “neutral” on 31st August during a Monday report. They also announced their target price on NASDAQ: STAA stocks at $58.00.
Meanwhile, BidaskClub decreased its rating of “Buy” to a rating of “hold” during a Thursday report. Jefferies Financial Group started its NASDAQ: STAA coverage on 15th June during a Monday report. They also announced a target price of $55.00 and a rating of “buy on STAAR Surgical stocks. Last but not the least, Canaccord Genuity upgraded its target price to $70.00 from $45.00. They also gave a rating of “buy” to the company on 8th July during a Wednesday report.
How Did Institutional Investors React To The Recent STAAR Surgical Report?
Capital International Investors increased their position holding at NASDAQ: STAA by 4.7 percent. They currently own an estimate of $61,888,000, which comes from 1,918,400 company shares. Geode Capital Management LLC also upgrades their holding at NASDAQ: STAA by 10.7 percent. They currently own an estimate of $17,234,000, which comes from 534,240 company shares. Loomis Sayles & Co also increased its STAAR Surgical shares by 19.3 percent. They currently win an estimate of $17,139,000, which comes from 531,290 company shares.
The Royal Bank of Canada also increased its NASDAQ: STAA shares by 12.2 percent. They currently own an estimate of $14,049,000, which comes from 435,514 company shares. Last but not the least, Principal Financial Group Increase also increased its STAAR Surgical shares by 68.1 percent. They currently own an estimate of $23,200,000, which comes from 376,976 company shares.
It should be noted 90.18 percent of STAAR Surgical stock is owned by hedge funds and stock market institutional investors.
On Friday, NASDAQ: STAA shares started at $58.07. The firm’s market capitalization stands at $2.66 billion. Their beta and price to earnings ratio stands at 1.43 and 362.96 respectively. STAAR Surgical Inc’s fifty days moving average is $52.27. Its two-hundred days moving average is $46.79. The company’s one year high is $62.51 and one year low is $23.20.
On 5th August, during a Wednesday report, NASDAQ: STAA announced its earnings for the quarter. As per reports, they earned $0.03 EPS.